Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal remifentanil for neonatal INSURE intubation
ACTRN12612000386831Phase 2Not yet recruiting
- Sponsor
- Associate Professor Ian Wright
- Start
- Jul 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of remifentanil, sponsored by Associate Professor Ian Wright. Planned start Jul 2012; status: not yet recruiting.
02
Drugs
remifentanil
Beyond the preview
Go deeper on ACTRN12612000386831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000386831.